Cambridge, England: AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research
12 November 2024 AstraZeneca invests $3.5 billionin R&D and manufacturing in the United States AstraZeneca today announces $3.5 billion of
1 November 2024 15:00 GMT Transparency DirectiveVoting rights and capital The following notification is made in accordance with the UK
7 October 2024 AstraZeneca strengthens its cardiovascular pipeline with agreement for a pre-clinical novel lipid-lowering therapy AstraZeneca has entered into
1 October 2024 15:00 BST Transparency DirectiveVoting rights and capital The following notification is made in accordance with the UK
13 September 2024 15:15 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announces that Michel Demaré, Non-Executive
Socially Bharat is your comprehensive source for Social news, NGO’s, and expert insights from across India.
Copyright© 2025 Creative Bharat Powered By A Buzz Company